Pet Rat Drug Dosing: A Vet Reference
PublishedJuly 31, 2026Reading time6 minExoticRx Editorial
Editorially reviewed against published veterinary references. Awaiting credentialed clinical reviewer — our editorial process.
Most pet rats die of respiratory disease, and most respiratory disease in pet rats is Mycoplasma pulmonis. That's the one-line rat-medicine summary; everything else about drug selection in this species follows from it. Pet rats live 2–3 years, the lung disease usually starts at 6 months, and by 18 months you're managing acute exacerbations of a chronic background infection rather than curing anything. The right drug choice is the one that the patient tolerates long-term — not the one with the cleanest single-course MIC.
This article is the practical reference: what to reach for, what to avoid, and the dose ranges modern small-mammal exotics specialists actually use.
ExoticRx maintains an actively curated pet rat formulary. Browse the rat formulary for live, source-cited data; this article is the editorial overview.
The Mycoplasma context
M. pulmonis is endemic in nearly all colony rats and most pet rats. It causes chronic respiratory disease (CRD), often with secondary Streptococcus pneumoniae / Pasteurella pneumotropica / Bordetella bronchiseptica / CAR bacillus (cilia-associated respiratory bacillus) co-infections. Antibiotic choice in a coughing rat is essentially a Mycoplasma + secondary-pathogen co-cover decision.
The drugs that work against Mycoplasma are limited (it has no cell wall, so β-lactams don't touch it):
- Doxycycline
- Enrofloxacin / marbofloxacin
- Azithromycin
- Chloramphenicol
And the drugs that DON'T work against Mycoplasma but are sometimes given anyway:
- Penicillins, amoxicillin, amoxicillin-clavulanate (no cell wall = no target)
- Cephalexin, cefadroxil
- Clindamycin (rats tolerate it, but no Mycoplasma activity)
Antibiotics
Enrofloxacin: 5–10 mg/kg PO, SC, or in drinking water q12h. The first-line drug for acute respiratory exacerbation. Add doxycycline for synergy in moderate-severe cases (the combination protocol is often called "Baytril–Doxy" by rat fanciers and has solid clinical-experience data). Keep on for 14–21 days minimum.
Doxycycline: 5 mg/kg PO q12h. Cornerstone of CRD management. Often paired with enrofloxacin for the first 14 days, then doxycycline alone for chronic suppression. Tolerated long-term in this species. The water-bottle delivery (50 mg in 250 mL water, refreshed daily) works for owners who can't reliably PO-dose twice daily — the rat's habitual drinking gets the dose.
Azithromycin: 30 mg/kg PO q24h × 5 days, then twice weekly for chronic. Useful as a third-line addition or rotation when doxycycline + enrofloxacin isn't holding. Long elimination half-life means twice-weekly maintenance dosing is feasible.
Chloramphenicol: 50 mg/kg PO q12h. Reserved for resistant cases or where co-infection with sulfonamide-resistant pathogens is suspected. Wear gloves when compounding (human aplastic anemia warning).
TMS (trimethoprim-sulfa): 30 mg/kg PO q12h. Useful for confirmed Streptococcus pneumoniae or skin infections; not effective against Mycoplasma alone but valuable as part of the secondary-pathogen cover.
Amoxicillin / amoxicillin-clavulanate: tolerated orally in rats (unlike rabbits — they're not hindgut fermenters). Useful for confirmed bite-wound abscess or non-respiratory bacterial disease. Don't reach for this in respiratory disease — no Mycoplasma activity.
Analgesia
Meloxicam: 1–2 mg/kg PO or SC q24h. Higher than the canine dose, similar to rabbit. Rats tolerate this well; the upper end is often needed for post-surgical analgesia or chronic mammary tumor pain. Hydration must be adequate.
Buprenorphine: 0.05–0.1 mg/kg SC q6–12h. Short-acting; the longer-duration depot formulations (Buprenorphine SR) at 0.6–1 mg/kg SC q72h are increasingly used for post-surgical pain and chronic tumor management — fewer handling stresses for the same coverage.
Tramadol: 5–10 mg/kg PO q12h. Adjunct for chronic musculoskeletal or tumor pain. Less reliable monotherapy than buprenorphine.
Local blocks (lidocaine 1–2 mg/kg + bupivacaine 1 mg/kg) for any procedure with a clear nerve target. Greatly reduces the systemic analgesia burden.
Antiparasitics
Ivermectin: 0.4 mg/kg SC, repeated in 14 days. Standard for fur mites (Radfordia ensifera, Ornithonyssus bacoti) and ear mites. Rats tolerate the topical formulation poorly — the oral solution diluted in water for SC injection is the practitioner default.
Selamectin: 6–12 mg/kg topical. Spot-on for external parasites; well-tolerated and avoids the injection.
Fenbendazole: 20 mg/kg PO q24h × 5 days. Routine intestinal nematodes; uncommon as a primary need in pet rats but useful for refractory pruritus when mites have been excluded.
Anaesthesia
Isoflurane: 3–4% mask induction → 1.5–2.5% maintenance via mask. Standard. Mask induction is straightforward. Some practitioners intubate with a 2.0–2.5 mm uncuffed tube; others manage on mask.
Pre-med: midazolam 0.5–1 mg/kg + buprenorphine 0.05 mg/kg SC, 30 minutes before. Reduces handling stress, lowers iso requirements, provides peri-operative analgesia.
Ketamine + xylazine: 60–90 mg/kg ketamine + 5–10 mg/kg xylazine IM. Older protocol, still used in some settings. Reverse with atipamezole or yohimbine at published rat/small-mammal doses (do not scale to 5× the xylazine dose — that ratio applies only to medetomidine); see the formulary. Slower recovery than mask induction.
Recovery: warm, dark, quiet. Rats are easy to recover but easy to dehydrate post-op — give SC fluids (10–25 mL/kg warmed Hartmann's) before discharge.
Mammary tumor management — the other big rat-medicine topic
Roughly 50% of intact female rats develop mammary tumors by 18 months. They're usually fibroadenomas (benign) but recur in 30–50% of patients post-surgical removal. Drug-side considerations:
Cabergoline: 0.6 mg/kg PO q72h. Reduces prolactin-driven tumor growth in confirmed prolactinomas. Off-label in rats but well-tolerated. Useful when surgical removal isn't feasible.
Deslorelin (Suprelorin): 4.7 mg implant SC. Suppresses estrogen and reduces recurrence risk in spayed or intact female rats. Newer but increasingly used.
Surgical removal is the primary treatment; drugs above are adjunct. Pre-op meloxicam + buprenorphine, post-op continued for 5 days.
What kills rats you shouldn't reach for
- Aspirin at high doses (renal toxicity, bleeding) — meloxicam is safer at the lower NSAID dose range
- Phenobarbital at canine epilepsy doses (rats metabolise it slower; toxicity)
- Permethrin — concentrated canine spot-on products are neurotoxic to rats (permethrin is also contraindicated in cats)
- Glucocorticoids long-term for any indication other than confirmed adrenal disease — rats develop iatrogenic Cushing-like signs and infection susceptibility quickly
- Chocolate / xylitol — same as dogs
Quick reference
| Indication | Drug / dose | Route | Cadence |
|---|---|---|---|
| Mycoplasma respiratory (acute) | Enrofloxacin 5–10 mg/kg + Doxycycline 5 mg/kg | PO or SC | Both q12h |
| Chronic respiratory suppression | Doxycycline 5 mg/kg | PO | q12h, long-term |
| Resistant respiratory | Azithromycin 30 mg/kg × 5d, then twice weekly | PO | q24h initially |
| Strep / secondary | TMS 30 mg/kg | PO | q12h |
| Bite wound / abscess | Amoxicillin-clavulanate 10–20 mg/kg | PO | q12h |
| Pain (NSAID) | Meloxicam 1–2 mg/kg | PO or SC | q24h |
| Pain (opioid, repeat) | Buprenorphine 0.05–0.1 mg/kg | SC | q6–12h |
| Pain (opioid, long-acting) | Buprenorphine SR 0.6–1 mg/kg | SC | q72h |
| Mites | Ivermectin 0.4 mg/kg | SC | Repeat at 14 days |
| Mites (alternate) | Selamectin 6–12 mg/kg | Topical | Once |
| Mammary tumour adjunct | Cabergoline 0.6 mg/kg | PO | q72h |
| Anaesthesia pre-med | Midazolam 0.5–1 + buprenorphine 0.05 mg/kg | SC | 30 min before |
| Anaesthesia maintenance | Isoflurane 1.5–2.5% | Inhalational | Continuous |
For per-drug live data, browse the rat formulary or calculate by weight directly against the source-cited database.
Sources
- Quesenberry K, Carpenter JW, eds. Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, 4th ed. Elsevier, 2020.
- Carpenter JW, Marion CJ, eds. Carpenter's Exotic Animal Formulary, 6th ed. Elsevier, 2023.
- Hawkins MG, Bishop CR. Disease problems of guinea pigs. (Cross-reference rodent chapter; covers many Mycoplasma protocol details applicable to rats.)
- Foley PL, Liang H, Crichlow AR. Evaluation of a sustained-release buprenorphine formulation in rats. J Am Assoc Lab Anim Sci. 2011;50(2):198–204.
- Plumb DC. Plumb's Veterinary Drug Handbook, 10th ed. Wiley, 2024.